Monash University scientist, Professor Jamie Rossjohn, has been elected to the Fellowship of the Academy of Medical Sciences in the UK. The Academy of Medical Sciences Fellows are considered the UK’s leading medical scientists, elected for their contribution to biomedical and health research, the generation of new knowledge in medical sciences and its translation into […]
https://rossjohnlab.com/wp-content/uploads/2018/02/019_AMS_AdmissionsDay2017_bigTimages-e1517473219340.jpeg529527Jennifer Huynh//rossjohnlab.com/wp-content/uploads/2018/01/monash.pngJennifer Huynh2017-07-04 16:49:192018-02-01 18:27:04Jamie Rossjohn elected into the Fellowship of the Academy of Medical Sciences, UK
Monash University has signed a major multiyear research and commercialisation deal with Janssen Biotech, Inc. (“Janssen”), one of the Janssen Pharmaceutical companies of Johnson & Johnson, for the early detection and prevention of rheumatoid arthritis, a debilitating autoimmune disease which affects more than 400,000 Australians1 and more than 24.5 million people worldwide2. The agreement was […]
Janssen Biotech funds Monash rheumatoid arthritis research Janssen Biotech, part of global giant Johnson & Johnson, has agreed to fund research by a team of scientists led by one of Monash University’s star researchers into rheumatoid arthritis. The landmark deal means Janssen will have first dibs on new medicines emerging from a research team led […]
https://rossjohnlab.com/wp-content/uploads/2018/02/Jamie-Rossjohn-Australian-Financial-Review-400px.jpg400400Jennifer Huynh//rossjohnlab.com/wp-content/uploads/2018/01/monash.pngJennifer Huynh2017-06-04 10:00:292018-02-02 09:02:02Jamie Rossjohn featured in the Australian Financial Review
Monash University’s innovative, world-leading research and its strong engagement with industry have helped secure significant funding in the latest Australian Research Council (ARC) grants for Linkage Projects. Monash University has been awarded AUD $2,261,074 to support six applied research projects, ranging from development of a wearable blood-pressure monitor and enhanced inhaler design for more efficient […]
https://rossjohnlab.com/wp-content/uploads/2018/01/018_Jamie-Rossjohn_400px.jpg310400Kyle//rossjohnlab.com/wp-content/uploads/2018/01/monash.pngKyle2017-05-31 15:14:252019-04-11 09:27:00Monash secures over AUD $2 million for industry Linkage Projects
Monash University researchers have discovered the mechanism that explains how key genetic risk factors cause or protect people from autoimmune disease such as type 1 diabetes, multiple sclerosis, and Crohn’s disease. Monash University researchers have discovered the mechanism that explains how key genetic risk factors cause or protect people from autoimmune disease such as type […]
https://rossjohnlab.com/wp-content/uploads/2017/05/eaglevaneete.png447341Jennifer Huynh//rossjohnlab.com/wp-content/uploads/2018/01/monash.pngJennifer Huynh2017-05-04 17:00:382018-05-02 14:35:40Unearthing the basis of Autoimmune Disease
Jamie Rossjohn elected into the Fellowship of the Academy of Medical Sciences, UK
/in News /by Jennifer HuynhMonash University scientist, Professor Jamie Rossjohn, has been elected to the Fellowship of the Academy of Medical Sciences in the UK. The Academy of Medical Sciences Fellows are considered the UK’s leading medical scientists, elected for their contribution to biomedical and health research, the generation of new knowledge in medical sciences and its translation into […]
Monash and Janssen Biotech collaborate on rheumatoid arthritis prevention
/in News /by Jennifer HuynhMonash University has signed a major multiyear research and commercialisation deal with Janssen Biotech, Inc. (“Janssen”), one of the Janssen Pharmaceutical companies of Johnson & Johnson, for the early detection and prevention of rheumatoid arthritis, a debilitating autoimmune disease which affects more than 400,000 Australians1 and more than 24.5 million people worldwide2. The agreement was […]
Jamie Rossjohn featured in the Australian Financial Review
/in News /by Jennifer HuynhJanssen Biotech funds Monash rheumatoid arthritis research Janssen Biotech, part of global giant Johnson & Johnson, has agreed to fund research by a team of scientists led by one of Monash University’s star researchers into rheumatoid arthritis. The landmark deal means Janssen will have first dibs on new medicines emerging from a research team led […]
Monash secures over AUD $2 million for industry Linkage Projects
/in News /by KyleMonash University’s innovative, world-leading research and its strong engagement with industry have helped secure significant funding in the latest Australian Research Council (ARC) grants for Linkage Projects. Monash University has been awarded AUD $2,261,074 to support six applied research projects, ranging from development of a wearable blood-pressure monitor and enhanced inhaler design for more efficient […]
Unearthing the basis of Autoimmune Disease
/in News /by Jennifer HuynhMonash University researchers have discovered the mechanism that explains how key genetic risk factors cause or protect people from autoimmune disease such as type 1 diabetes, multiple sclerosis, and Crohn’s disease. Monash University researchers have discovered the mechanism that explains how key genetic risk factors cause or protect people from autoimmune disease such as type […]